GROV Q1 2026 Earnings Significant EPS Beat Surprises Market THRY Q1 2026 Earnings Stellar EPS Beat Drives Stock Surge ACIU Q1 2026 Earnings Narrower Net Loss Highlights Cost Discipline in PreRevenue Phase CPS Q1 2026 Earnings Earnings Miss Estimates Significantly as EPS Falls Short JSPR Q1 2026 Earnings Stunning EPS Beat Highlights Cost Discipline as PreRevenue Biotech Advances Pipeline Castle Biosciences Q1 2026 Earnings Narrowly Beats EPS Estimates but Stock Declines